|
|
Br J Ophthalmol. 1987 September; 71(9): 651–658. | PMCID: PMC1041268 |
Radioimmunoscintigraphy of ocular melanoma with 99mTc labelled cutaneous melanoma antibody fragments. J. Bomanji, J. L. Hungerford, M. Granowska, and K. E. Britton Department of Nuclear Medicine, St Bartholomew's Hospital, London. Abstract The possibility of using radiolabelled monoclonal antibody fragments to image uveal melanomas has been assessed in a pilot study. 99mTc labelled F(ab')2 fragments of MoAb 225.28S raised against cutaneous melanomas were used. Initially 10 patients were imaged. In five patients the clinical findings were typical of uveal melanoma. Immunoscintigraphy was positive in all five cases. In a further five patients there was doubt about the diagnosis. One was though to have a choroidal haemangioma but failed to respond to treatment and immunoscintigraphy was positive, suggesting a diagnosis of melanoma. Two patients were assigned a diagnosis of choroidal haemangioma, one of melanocytoma or possible retinal pigment epithelium carcinoma, and one of metastasis. Immunoscintigraphy was negative in all these four cases. In combination with established diagnostic tests immunoscintigraphy may have a part to play in differentiating uveal melanoma from other similar tumours. Full text Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (2.5M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References. Images in this article Click on the image to see a larger version. These references are in PubMed. This may not be the complete list of references from this article. - Hagler WS, Jarrett WH, 2nd, Killian JH. The use of the 32P test in the management of malignant melanoma of the choroid: a five-year follow-up study. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol. 1977 JanâFeb;83(1):49–60. [PubMed]
- Van Dijk RA. The 32P test and other methods in the diagnosis of intraocular tumors. (Thesis). Doc Ophthalmol. 1978 Oct 16;46(1):1–132. [PubMed]
- Shields JA. Accuracy and limitations of the 32P test in the diagnosis of ocular tumors: an analysis of 500 cases. Ophthalmology. 1978 Sep;85(9):950–966. [PubMed]
- Shammas HF, Burton TC, Weingeist TA. False-positive results with the radioactive phosphorus test. Arch Ophthalmol. 1977 Dec;95(12):2190–2192. [PubMed]
- Zakov ZN, Smith TR, Albert DM. False-positive 32P uptake tests. Arch Ophthalmol. 1978 Dec;96(12):2240–2243. [PubMed]
- McLean IW, Zimmerman LE, Evans RM. Reappraisal of Callender's spindle a type of malignant melanoma of choroid and ciliary body. Am J Ophthalmol. 1978 Oct;86(4):557–564. [PubMed]
- Williams AT, Font RL, Van Dyk HJ, Riekhof FT. Osseous choristoma of the choroid simulating a choroidal melanoma. Association with a positive 32P test. Arch Ophthalmol. 1978 Oct;96(10):1874–1877. [PubMed]
- Dencker L, Larsson B, Olander K, Ullberg S. A new melanoma seeker for possible clinical use: selective accumulation of radiolabelled thiouracil. Br J Cancer. 1982 Jan;45(1):95–104. [PubMed]
- Coderre JA, Packer S, Fairchild RG, Greenberg D, Laster B, Micca P, Fand I. Iodothiouracil as a melanoma localizing agent. J Nucl Med. 1986 Jul;27(7):1157–1164. [PubMed]
- Hoffer P. Status of gallium-67 in tumor detection. J Nucl Med. 1980 Apr;21(4):394–398. [PubMed]
- DeLand FH, Goldenberg DM. Diagnosis and treatment of neoplasms with radionuclide-labeled antibodies. Semin Nucl Med. 1985 Jan;15(1):2–11. [PubMed]
- Bomanji J, Garner A, Prasad J, Albert DM, Hungerford JL, Granowska M, Britton KE. Characterisation of ocular melanoma with cutaneous melanoma antibodies. Br J Ophthalmol. 1987 Sep;71(9):647–650. [PubMed]
- Buraggi GL, Callegaro L, Mariani G, Turrin A, Cascinelli N, Attili A, Bombardieri E, Terno G, Plassio G, Dovis M, et al. Imaging with 131I-labeled monoclonal antibodies to a high-molecular-weight melanoma-associated antigen in patients with melanoma: efficacy of whole immunoglobulin and its F(ab')2 fragments. Cancer Res. 1985 Jul;45(7):3378–3387. [PubMed]
- Buraggi GL, Callegaro L, Turrin A, Cascinelli N, Attili A, Emanuelli H, Gasparini M, Deleide G, Plassio G, Dovis M, et al. Immunoscintigraphy with 123I, 99mTc and 111In-labelled F(ab')2 fragments of monoclonal antibodies to a human high molecular weight-melanoma associated antigen. J Nucl Med Allied Sci. 1984 Oct–Dec;28(4):283–295. [PubMed]
- Wilson BS, Ruberto G, Ferrone S. Immunochemical characterization of a human high molecular weight--melanoma associated antigen identified with monoclonal antibodies. Cancer Immunol Immunother. 1983;14(3):196–201. [PubMed]
- Wilson BS, Imai K, Natali PG, Ferrone S. Distribution and molecular characterization of a cell-surface and a cytoplasmic antigen detectable in human melanoma cells with monoclonal antibodies. Int J Cancer. 1981 Sep 15;28(3):293–300. [PubMed]
- Bumol TF, Reisfeld RA. Unique glycoprotein-proteoglycan complex defined by monoclonal antibody on human melanoma cells. Proc Natl Acad Sci U S A. 1982 Feb;79(4):1245–1249. [PubMed]
- Natali PG, Bigotti A, Cavaliere R, Nicotra MR, Ferrone S. Phenotyping of lesions of melanocyte origin with monoclonal antibodies to melanoma-associated antigens and to HLA antigens. J Natl Cancer Inst. 1984 Jul;73(1):13–24. [PubMed]
- Natali PG, Imai K, Wilson BS, Bigotti A, Cavaliere R, Pellegrino MA, Ferrone S. Structural properties and tissue distribution of the antigen recognized by the monoclonal antibody 653.40S to human melanoma cells. J Natl Cancer Inst. 1981 Sep;67(3):591–601. [PubMed]
- Ng AK, Giacomini P, Kantor R, Ferrone S. Molecular heterogeneity and shedding of a high-molecular-mass melanoma-associated antigen identified with monoclonal antibodies. Clin Chem. 1982 Dec;28(12):2347–2350. [PubMed]
- Green AJ, Begent RH, Keep PA, Bagshawe KD. Analysis of radioimmunodetection of tumors by the subtraction technique. J Nucl Med. 1984 Jan;25(1):96–100. [PubMed]
- Granowska M, Britton KE, Shepherd JH, Nimmon CC, Mather S, Ward B, Osborne RJ, Slevin ML. A prospective study of 123I-labeled monoclonal antibody imaging in ovarian cancer. J Clin Oncol. 1986 May;4(5):730–736. [PubMed]
|